• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Cost-Sharing Roundtable—Introduction

Video

Healthcare cost-sharing remains a significant barrier to healthcare access, especially among patients with chronic conditions or those with financial constraints, and could prevent patients from getting much-needed health services, use of diagnostic tests, or result in adherence issues due to patients skipping doses or not filling their prescription medications. At the Cost-Sharing Roundtable on February 23, 2018, presenters and panelists—from academic institutions, health policy organizations, and charitable foundations—shared their findings and experiences with financial hardships faced by patients, and brain stormed ideas on how best to address the situation via practical advice and policy changes.

Healthcare cost-sharing remains a significant barrier to healthcare access, especially among patients with chronic conditions or those with financial constraints, and could prevent patients from getting much-needed health services, use of diagnostic tests, or result in adherence issues due to patients skipping doses or not filling their prescription medications.

At the Cost-Sharing Roundtable on February 23, 2018, presenters and panelists—from academic institutions, health policy organizations, and charitable foundations—shared their findings and experiences with financial hardships faced by patients, and brain stormed ideas on how best to address the situation via practical advice and policy changes.

Speakers:

Amy Niles, vice president of external relations of the Patient Access Network (PAN) Foundation

Surabhi Dangi-Garimella, PhD, associate editorial director, The American Journal of Managed Care®

Dan Klein, president and CEO of the PAN Foundation.

Related Videos
Dr Brian Slomovitz
Reynold Panettieri, Jr, MD
Dirk Arnold, MD, PhD, medical director, Asklepios Tumour Biology Centre
Jill Feldman, patient, cofounder and president, EGFR Resisters
Reynold Panettieri, Jr, MD
Danny Rischin, MD, medical oncologist, clinician researcher, Peter McCallum Cancer Centre
James Chalmers, MD
Ibrahim Aldoss, MD, associate professor, City of Hope
James Chalmers, MD
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.